a r t I C l e S Autism spectrum disorders (ASDs) constitute a heterogeneous group of neurodevelopmental conditions characterized by impairments in two core domains: communication and social behavior and repetitive and stereotyped actions 1,2 . Behavioral interventions for social deficits have been suggested, while pharmacotherapy is limited to reducing ASD symptoms such as irritability (for example, risperidone), but fails to address impairments in any of the core domains. To aid the development of new treatment options, a better understanding of how brain circuits controlling social and repetitive behaviors are altered in ASDs is required.
a r t I C l e S Autism spectrum disorders (ASDs) constitute a heterogeneous group of neurodevelopmental conditions characterized by impairments in two core domains: communication and social behavior and repetitive and stereotyped actions 1, 2 . Behavioral interventions for social deficits have been suggested, while pharmacotherapy is limited to reducing ASD symptoms such as irritability (for example, risperidone), but fails to address impairments in any of the core domains. To aid the development of new treatment options, a better understanding of how brain circuits controlling social and repetitive behaviors are altered in ASDs is required.
Brain regions involved in the control of social behavior and repetitive actions show a surprising degree of overlap, encompassing corticolimbic-ventral striatal networks 3, 4 . Notably, these regions are subject to modulation by DA neurons of the ventral tegmental area (VTA) and a growing body of literature points to impaired function of this 'reward circuit' as contributing to social deficits in ASDs 5, 6 . For example, according to the social motivation hypothesis of autism, social interactions would normally occur because they are inherently rewarding, but individuals with ASDs show a deficit in assigning value to social stimuli resulting in social dysfunction 6 . Midbrain DA neurons signal motivationally relevant stimuli 7, 8 , and fiber photometry has revealed an increase in VTA DA neuron Ca 2+ activity during social interactions 9 . However, how genetic risk factors affect VTA function and the mechanisms by which this affects social behavior has not been explored.
Although the etiology of autism is unclear, twin studies highlight a strong genetic component of the disease 10 . Many of the genes implicated in ASDs encode for synaptic proteins and, for this reason, autism is considered a 'synaptopathy' 11 . SHANK3 is one such gene, encoding the excitatory synapse scaffolding protein SHANK3, whose loss or mutation is associated with Phelan-McDermid syndome 12 and other isolated cases of ASD 13, 14 . Through its different domains, SHANK3 orchestrates the layout of metabotropic and ionotropic glutamate receptors at the synapse 15 . For example, the PDZ region is responsible for the indirect link of NMDA receptors (NMDARs) and AMPA receptors (AMPARs), while the proline-rich domain of SHANK3 binds to metabotropic glutamate receptor (mGluR) group I via the Homer protein. In mutant mice with disruptions of distinct SHANK3 domains, a variety of electrophysiological and behavioral phenotypes were reported [16] [17] [18] [19] [20] . While such knockout models underscore the importance of Shank3 deficiency in impairing behavior, how dysfunction in specific brain circuits may contribute to specific behavioral deficits has not been fully resolved.
The peak of Shank3 gene expression occurs within the first postnatal week and decreases during the second and third weeks, a critical period of development when activity shapes neuronal connectivity and circuit function. We have previously shown that during the first postnatal week in mice, AMPAR transmission to VTA DA neurons is mainly mediated by GluA2-lacking Ca 2+ permeable AMPARs 21 . Activation of metabotropic mGluR1 during postnatal development removes these calcium-permeable AMPARs and inserts GluA2-containing receptors. Notably, removal of mGluR1 or exposure to addictive drugs in utero impairs the postnatal maturation of glutamatergic transmission to VTA DA neurons, resulting in persistent and aberrant expression of GluA2-lacking AMPARs 21, 22 . Given the importance of SHANK3 in orchestrating excitatory synaptic function, a r t I C l e S we hypothesized that low levels of SHANK3 in the VTA could also affect the maturation of excitatory synapses in this structure, driving long-lasting synaptic, circuit and behavioral deficits that could contribute to the pathology of ASDs.
Here we use a shRNA to induce early postnatal downregulation of SHANK3 specifically in the VTA. The resulting SHANK3 insufficiency impairs the maturation of excitatory synapses onto both VTA DA and GABA neurons. These synaptic changes are concomitant with reduced in vivo burst activity of DA neurons, increased activity of GABA neurons and behavioral deficits including impaired social preference that persists into adulthood. Providing a causal link between altered DA neuron activity and social behavior, we find that systemic treatment with a positive allosteric modulator (PAM) of mGluR1 during the postnatal period of synapse maturation normalizes social deficits into adulthood, owing to a specific partial rescue of DA neuron excitatory transmission and activity. Moreover, optogenetic activation of VTA DA neurons increases social preference in SHANK3-deficient mice, confirming sufficiency of DA neuron activity to support social interactions.
RESULTS

SHANK3 insufficiency alters VTA excitatory synaptic transmission
To isolate the potential impact on the VTA caused by global SHANK3 deficiency in some ASD cases, we downregulated SHANK3 (ref. 23) in the VTA of mice before postnatal day (P) 6 using stereotaxic injections of adeno-associated virus (AAV) expressing an shRNA that targets the proline-rich domain encoding a region of Shank3 mRNA (shShank3), coupled with the ZsGreen reporter (Fig. 1a) . Construct expression was evident 9 d after the injection (Supplementary Fig. 1a) , persisted when synapses were mature (more than 20 weeks; data not shown) and was restricted to the VTA, where 61.1% of DA neurons (tyrosine hydroxylase-positive, TH + ) and 39.5% of non-DA cells (i.e., non-TH cells) were infected (Supplementary Fig. 1b) . To better quantify the proportion of VTA GABA cells infected, GAD-Cre mice were injected with AAV-DIO-tdTomato at postnatal day (P) 14 allowing the specific identification of GABA neurons (Fig. 1b) . Quantification of ZsGreen expression in TH + and tdTomato-labeled cells confirmed shShank3 expression in 53.5% of DA neurons and 31.4% of GABA neurons, respectively (Fig. 1b) . Western-blot analysis of the VTA, dissected at adolescence, showed a significant decrease in SHANK3 expression in AAV-shShank3 mice compared to animals infected with a scrambled sequence (AAVscrShank3; Fig. 1c) . No difference in SHANK3 expression was found in the neighboring substantia nigra (Fig. 1c) , indicating that our manipulation was selective for the VTA. Although we did not examine whether morphological changes occurred in VTA neurons, the number of TH + cells did not differ when comparing AAV-shShank3-infected and uninfected sides in the same animal (Supplementary Fig. 1c) , suggesting that shShank3 expression was not affecting cell survival.
Since SHANK3 is enriched in the postsynaptic density of excitatory synapses 15 , we examined whether early postnatal Shank3 downregulation in the VTA could give rise to alterations in excitatory synaptic transmission to VTA neurons. Whole cell in vitro patch clamp recordings from shShank3-or scrShank3-infected cells were performed and excitatory postsynaptic currents (EPSCs) pharmacologically isolated. We recorded from putative DA neurons identified by their high capacitance, low input resistance ( Supplementary Fig. 2a,b) , presence of the hyperpolarization-activated current I h current and morphology. Recordings were made when the postnatal maturation of VTA DA neuron synapses is normally complete (P18-35; early adolescence) 21 . Putative DA neurons infected with shShank3 exhibited a higher AMPA-to-NMDA ratio (AMPA/NMDA) compared to scrShank3 or uninfected neurons (Fig. 2a) . There was no change in the paired pulse ratio (PPR), pointing to a postsynaptic locus of this effect (Fig. 2b) npg a r t I C l e S At VTA DA neuron synapses, an aberrant increase in the AMPA/ NMDA ratio often reflects functional changes in the AMPAR subunit arrangement 24, 25 . To analyze the AMPAR subunit composition, AMPARmediated EPSCs were pharmacologically isolated and the rectification index (RI) was calculated as the slope of the line between current measured at negative and reversal potentials divided by the corresponding slope measured at positive potentials 26 . An increase in RI was observed in shShank3-infected putative DA neurons compared to both scrShank3 and uninfected putative DA cells (Fig. 2c) . Changes in AMPAR can occur together with changes in NMDAR subunit composition 21 . However, no change in sensitivity to the NMDA receptor subunit 2B (GluN2B) antagonist ifenprodil or decay time kinetics was found in shShank3-infected compared to uninfected cells (Fig. 2d-f) , indicating that the ratio of GluN2B-containing to GluN2A-containing NMDARs was not affected by SHANK3 insufficiency. Collectively, these data reveal the presence of GluA2-lacking AMPARs at excitatory synapses onto VTA putative DA neurons of adolescent mice, with no change in NMDAR subunit composition following early postnatal VTA SHANK3 insufficiency.
How does VTA SHANK3 insufficiency alter excitatory transmission? In VTA DA neurons, GluA2-lacking AMPARs contribute to synaptic transmission at birth and are then exchanged for GluA2-containing AMPARs during postnatal synapse maturation 21 . One possibility is that SHANK3 insufficiency prevents this physiological maturation of DA neuron synapses. Alternatively, SHANK3 downregulation could alter synaptic transmission irrespective of any developmental influence. To distinguish between these two scenarios, we introduced AAV-Shank3 into the VTA after the postnatal period of synapse maturation 21 (Fig. 2g) . When SHANK3 was downregulated in the VTA after P20-P24, excitatory transmission recorded at P31-P45 remained unaltered (Fig. 2g,h ). These data suggest that SHANK3 is required for the maturation of excitatory transmission of VTA DA neurons and that, once maturation is completed, basal synaptic transmission becomes independent of SHANK3.
We next examined whether postnatal SHANK3 insufficiency affects excitatory transmission to VTA GABA neurons. Putative GABA neurons were identified by their low capacitance, high input resistance ( Supplementary Fig. 2a,b) , absence of I h and characteristic morphology. The AMPA/NMDA ratio was higher in shShank3-infected putative GABA neurons than in uninfected cells, while RI and PPR did not differ (Fig. 3a-c) . Thus, VTA SHANK3 insufficiency also alters glutamatergic transmission to VTA putative GABA neurons but, in contrast to putative DA neurons, this manipulation does not affect the content of GluA2-containing AMPARs at these synapses where, to the best of our knowledge, the presence of these receptors has never been investigated during development. These data point to cell-type-specific functions of SHANK3 within the VTA.
Positive allosteric modulation of mGluR1
In the VTA, pharmacological activation of mGluR1 on DA neurons promotes the switch from GluA2-lacking to GluA2-containing AMPARs 24, 26 . We first asked whether this approach could also reverse the delayed maturation observed with SHANK3 insufficiency. We monitored AMPAR EPSCs in VTA putative DA neurons from adolescent mice infected before P6 and bath applied the group I mGluR agonist DHPG (20 µM) . This led to a long-term depression and rendered the current-voltage relationship of AMPAR transmission linear (Fig. 4a,b) . 
a r t I C l e S
No long-term changes in AMPAR-mediated transmission or RI were observed after DHPG application in uninfected putative DA cells (Fig. 4a,b) . DHPG induced a transient short-term depression in both shShank3 and uninfected cells, which likely reflects release of endocannabinoids, as previously described 27 (Fig. 4a) . In VTA GABA putative neurons, DHPG treatment did not induce long-lasting changes in AMPAR EPSCs recorded from shShank3-infected nor uninfected putative GABA neurons ( Supplementary Fig. 3a) .
Together, these results show that pharmacological activation of group I mGluRs in acute brain slices rescue immature AMPAR-transmission through removal of GluA2-lacking AMPARs in putative DA but not in putative GABA neurons. Would such treatment also be efficient if administered in vivo? For this purpose we used a PAM of mGluR1 (Ro 677476; PAMmGluR1), which offers several advantages Vehicle s c r S h a n k 3 s h S h a n k 3 s c r S h a n k 3 s h S h a n k 3 Vehicle Ro 677476
Putative s c r S h a n k 3 s h S h a n k 3 s c r S h a n k 3 s h S h a n k 3 Vehicle Ro 677476 a r t I C l e S over DHPG, including selectivity for mGluR1 and facilitation of existing endogenous activity 28 . The PAM-mGluR1 was administered systemically (4 mg per kg, intraperitoneal injections) once daily starting from P6 until 24 h before ex vivo electrophysiological recordings performed between P18 and P33 ( Fig. 4c) . In PAM-mGluR1-treated shShank3 animals, the AMPA/NMDA ratio and RI in VTA putative DA neurons were no different from those in vehicle scrShank3 mice but significantly lower than those in shShank3 mice treated with vehicle ( Fig. 4c,d ). PAMmGluR1 treatment did not affect baseline transmission to VTA putative DA neurons in scrShank3 mice. Consistent with the in vitro DHPG data, the AMPA/NMDA ratio recorded at excitatory inputs to VTA GABA neurons remained elevated following PAM-mGluR1 treatment ( Supplementary Fig. 3b ). These data indicate that in vivo PAM-mGluR1 treatment acts specifically at synaptic inputs to putative DA neurons to normalize the maturation deficit induced by SHANK3 insufficiency.
SHANK3 insufficiency alters VTA neuron activity Group I mGluRs regulate the firing pattern of DA neurons both in vivo and in vitro 29, 30 . Insufficiency of SHANK3 might therefore lead to altered VTA neuron activity. We performed in vivo singleunit recordings in adolescent mice previously injected with AAVshShank3 virus. We found that the total fraction of VTA putative DA 31 neurons classified as 'burst-firing' was similar in shShank3 mice and scrShank3 controls ( Fig. 5a and Supplementary Fig. 4a,b) . However, while baseline firing rate did not significantly differ among conditions, within the population of burst-firing neurons the frequency within burst (bursting rate) was significantly lower in shShank3 mice than in controls ( Fig. 5b-d) . Conversely, the firing rate of putative GABA neurons (for identification parameters, see Online Methods) was significantly higher in shShank3 mice than in scrShank3 controls (Fig. 5e,f) . Thus, as seen in vitro, SHANK3 insufficiency leads to cell-type-specific changes in the activity of VTA neurons. Since VTA GABA neurons provide local inhibition to DA neurons 32 , their increased activity may further reduce DA neuron output. Was PAM-mGluR1 treatment in vivo also sufficient to recover VTA putative DA neuron activity following SHANK3 insufficiency? As before, following early postnatal VTA injections of AAV-shShank3 or AAV-scrShank3, we gave mice once-daily injections of PAM-mGluR1 during the period of synapse maturation. After these injections, burst activity of putative DA neurons was not different in shShank3 versus scrShank3 mice (Fig. 5b-d) . Taken together, these findings confirm that the activation of mGluR1 during synapse maturation partially rescues the maturation deficits in VTA DA neurons arising from SHANK3 insufficiency.
VTA SHANK3 insufficiency generates social impairments Shank3 knockout mice exhibit a variety of behavioral deficits, including increased self-grooming and social interaction deficits 16, 18, 33 . Since DA neuron activity has been shown to encode social interactions 9 , we hypothesized that VTA SHANK3 insufficiency may affect behaviors in the social domain.
First we assayed social preference in mice, using a three-chamber social interaction test 34 . In scrShank3 control mice, social preference e <P6 d s c r S h a n k 3 s h S h a n k 3 s c r S h a n k 3 s h S h a n k 3
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Vehicle Ro 677476 Firing frequency (Hz) Cumulative probability Putative GABA neurons P21−P35 P = 0.043 s c r S h a n k 3 s h S h a n k 3 npg a r t I C l e S was maintained for the entire duration of the 10-min test (Fig. 6a-c) . In contrast, in shShank3 mice, social preference significantly declined after 5 min (Fig. 6c,d) , suggesting a time-dependent loss of social interest. Further analysis showed that reduced social preference could be explained by a shorter social interaction time and a trend toward decreased number of entries (Fig. 6e,f) at the expense of a longer object interaction time during the second half of the observation period, Supplementary Fig. 5c ). These effects were not observed in the first half of the observation period, T 1 ( Supplementary Fig. 5a,b) . Impaired social preference was also observed in mice injected with a smaller volume of shShank3 virus (50 nL; Supplementary Fig. 6a-g ), while no difference was found in a test of social memory between shShank3 mice and controls ( Supplementary Fig. 6h-k) , strengthening the case for specific involvement of VTA in social preference.
To examine whether impaired social preference was accompanied by a generalized anhedonic behavior-that is, a reduction in interest in natural reward-we performed a sucrose preference test by comparing intake of different sucrose concentrations to water ( Supplementary  Fig. 6l-o) . ShShank3 mice preferred the sucrose solution at a high concentration, but not at a low concentration. However, shShank3 mice consumed more water during the low sucrose concentration condition (Supplementary Fig. 6m) , which led to the observed decreased sucrose preference ratio (Supplementary Fig. 6l ). Taken s c r S h a n k 3 s h S h a n k 3 s c r S h a n k 3 s h S h a n k 3 s c r S h a n k 3 s h S h a n k 3 s c r S h a n k 3 s h S h a n k 3 s c r S h a n k 3 s h S h a n k 3 s c r S h a n k 3 s h S h a n k 3 npg a r t I C l e S together, it is unclear how broadly VTA SHANK3 insufficiency affects behaviors motivated by natural rewards. Finally, mice were assessed for general activity levels in an openfield arena. There was no evidence for altered thigmotaxis or locomotor activity between shShank3 mice and controls ( Supplementary  Fig. 7a-c) . However, during this test, shShank3 mice exhibited higher levels of self-grooming than scrShank3 controls ( Supplementary  Fig. 7d) . Although levels of self-grooming were insufficient to induce skin lesions, these observations provide some, albeit limited, evidence for increased repetitive behavior following VTA SHANK3 insufficiency. No differences in body weight were observed between scrShank3 and shShank3 vehicle treated mice (Supplementary Fig. 7e,f) . Collectively, our behavioral analyses indicate that VTA SHANK3 insufficiency leads to behavioral alterations, including decreased time interacting with conspecifics and increased self-grooming.
Requirement for VTA DA neuron activity in social preference Could impaired social preference be ascribed to altered function of VTA DA or GABA neurons? Since PAM-mGluR1 treatment acted to specifically normalize DA neuron synaptic function and activity (Figs. 4 and 5) , we took advantage of this finding to examine whether this cell-type-specific rescue would be sufficient to normalize social behavior. Thus, following early postnatal intra-VTA AAV-shShank3 or scrShank3 injections, mice received once-daily systemic injections of PAM-mGluR1 during the period of synapse maturation (P6-P27) until 24 h before the three-chamber social interaction test (Fig. 6a) . While PAM-mGluR1 treatment did not affect social preference dynamics in scrShank3 control mice, social preference dynamics were partially rescued in shShank3 animals ( Fig. 6b-f and Supplementary Fig. 5a-h ). Locomotor parameters, such as the velocity and distance traveled during the test, did not differ between the groups (Supplementary Fig. 5i,j) . These data indicate that altered VTA putative DA neuron function is a key mechanism by which VTA SHANK3 insufficiency generates impaired social preference.
Is the rescue of postnatal maturation with PAM-mGluR1 permanent? To test this possibility, we downregulated SHANK3 during the early postnatal period, then treated the mice with the PAM-mGluR1 (P6-P27) and looked at synaptic transmission and behaviors in adult animals (Fig. 7a) . In control shShank3 mice that received vehicle instead of the PAM-mGluR1, we observed a high AMPA/NMDA ratio (Fig. 7b) and a reduction in social preference during T 2 ( Fig. 7c  and Supplementary Fig. 8a,b) , replicating the findings described above. In contrast, PAM-mGluR1 treatment during early life reduced the AMPA/NMDA ratio (Fig. 7b) and normalized social preference (Fig. 7c,d) . Thus, PAM-mGluR1 treatment during postnatal development ameliorates both synaptic alterations and behavioral deficits caused by SHANK3 insufficiency.
This pharmacological rescue suggests that normal VTA DA neuron activity may be sufficient for the maintenance of social preference. We performed optogenetic stimulation of VTA DA neurons during the three-chamber social interaction test in shShank3-injected mice. Channelrhodopsin (ChR2) was selectively expressed in VTA DA neurons by injecting AAV-DIO-ChR2 into the VTA of DAT-Cre mice previously infected with shShank3 or scrShank3 (Fig. 8a,b) . To validate the approach, we determined that blue light stimulation induced reliable bursts of action potentials in VTA DA neurons recorded from acute Normalized SP 2 T 2 off T 2 on s c r S h a n k 3 s h S h a n k 3 s c r S h a n k 3 s h S h a n k 3 npg a r t I C l e S slices of shShank3 mice (Fig. 8c,d) . In vivo, we stimulated VTA DA neurons 35 during T 2 when mice were in close proximity to the social stimulus (Fig. 8e) . ShShank3 mice that did not receive optogenetic stimulation showed a reduction in social preference at T 2 ( Fig. 8f,g ). However, phasic stimulation of VTA DA neurons increased social preference during T 2 in both scrShank3 and shShank3 mice (Fig. 8f) and increased normalized social preference of shShank3 mice to the levels of the scrShank3 control group (Fig. 8g) . It should be noted that Ro 677476 and optogenetics, perhaps through different mechanisms, have distinct effects on social behavior.These findings demonstrate that DA neuron activity is sufficient to support social preference and show that such stimulation protocols can overcome impaired social behavior attributable to SHANK3 downregulation.
DISCUSSION
With a growing body of evidence pointing to the involvement of VTA in both social behavior and repetitive actions 3, 4 , our study examines whether and how deficits in these behavioral domains could arise from haploinsufficiency of a gene linked to ASD. We found that VTA SHANK3 downregulation altered excitatory transmission to both DA and GABA neurons. Together they dampened the firing activity of DA neurons, with an impact on social preference. Treatment with a PAM-mGluR1 during the initial period of postnatal development was sufficient to reverse deficits in social preference, which remained normal in adult animals. Moreover, DA neuron burst firing activity is sufficient to support social preference and overcome social impairments arising from VTA SHANK3 insufficiency. Taken together, these results argue for a central role of perturbed VTA DA neuron maturation in the development of social preference. Several mouse models have been generated to study the consequences of Shank3 deletion 33 . Focusing on the postsynaptic density of striatal neurons, a reduction in the expression of GluA2, GluN2A and GluN2B has been observed in Shank3 knockout mice lacking the PDZ-containing SHANK3 isoforms (where PDZ is a protein interaction domain named after a common structure found in PSD-95, discs large, and zona occludens 1 proteins) 16 . In mouse models targeting the ankyrin-repeat domain of SHANK3, a reduction in the expression of GluA1 and GluN2A subunits has been reported in the hippocampus, although no changes in basal synaptic transmission were found 18 . Meanwhile, deletion of exon 21 resulted in no major changes in synaptic ionotropic receptor subunits in whole hippocampal homogenates 19 . Here we find that downregulation of the proline-rich-domain-containing isoforms of SHANK3 has different consequences for basal synaptic transmission depending on the neuronal cell type within the same brain region. Specifically, the AMPAR subunit composition was altered only at excitatory synapses onto DA neurons, where SHANK3 downregulation promoted the insertion of GluA2-lacking AMPARs. However, in VTA GABA neurons, SHANK3 downregulation changed the AMPA/NMDA ratio but left the AMPAR subunit composition unaffected. Taken together, the variety of synaptic alterations reported in different mutant mouse models may reflect disruptions of distinct Shank3 domains, whose expression is further regulated in a brain-region-specific and cell-type-specific manner.
In VTA DA neurons, activation of mGluR1 during postnatal development drives synaptic maturation by exchanging GluA2-lacking for GluA2-containing AMPARs 21 . This may establish competent DA neuron function, which in adulthood is required to assign emotional valence to salient stimuli 36 . We find that SHANK3 downregulation prevents the postnatal maturation of AMPAR transmission to VTA DA neurons and that affected synapses remain in an immature state. Thus, SHANK3 may serve to guarantee optimal functionality of mGluR1 and its signaling pathway during synaptic maturation of VTA DA neurons. Boosting mGluR1 signaling with a PAM during the period of synaptic development may overcome SHANK3 deficiency and drive the exchange of immature for mature receptors on VTA DA neurons. Surprisingly, at excitatory synapses onto VTA GABA neurons, we did not observe the presence of GluA2-lacking AMPARs when SHANK3 was downregulated, and PAM-mGluR1 treatment was unable to rescue synaptic deficits. These findings are in agreement with our previous observations that mGluR1-induced long-term depression (mGluR1-LTD) is contingent on the presence of GluA2-lacking AMPARs at the synapses 26 . A different expression of group I mGluRs 37 , a different synaptic localization of SHANK3 or mechanisms of synaptic maturation that may differ between VTA DA and GABA neurons could also explain our results.
Interfering with the expression of Shank3 in the VTA triggers multiple alterations in synapses and circuits that together reduce DA neuron activity. Other studies have shown that SHANK3 insufficiency can alter cell morphology 15 , and DA and GABA morphological changes should be examined in future studies. At the cellular level, reduced DA neuron activity could arise from a change in mGluR1 signaling following SHANK3 downregulation. Indeed, the burst activity of DA neurons is regulated by NMDAR and group I mGluR activation 29 . Precisely how changes in excitatory synaptic transmission and cellintrinsic properties interact to determine DA neuron activity warrants further investigation. In addition, VTA DA neurons receive inhibition from local GABA neurons 32, 38 , whose increased activity following SHANK3 downregulation may further dampen the activity of the DA neurons. Nevertheless, the central role of DA neuron activity in supporting social interactions is supported by our findings that restoring synaptic transmission to DA neurons with PAM-mGluR1 treatment and optogenetic activation of DA neurons were both sufficient to ameliorate social behavior in VTA SHANK3-deficient mice.
How might perturbed VTA DA neuron activity lead to deficits in social behavior? Several studies have implicated DA in social bonding 39, 40 . It has been suggested that DA neuron activity directly influences social choice 41 and facilitates choice of familiar partners 42 . Recently, it has been shown that activity of DA neurons, measured by monitoring cellular calcium dynamics, increases during social but not object interaction 9 . Since DA neurons project widely throughout the corticolimbic system, it would be of interest to understand how regions downstream of VTA DA neurons contribute to behavioral impairments reported here. Projections to the nucleus accumbens may be particularly relevant, since their activity predicts social interactions in freely moving mice, possibly by controlling the firing of D1 dopamine receptor-expressing medium spiny neurons 9 .
In addition to impaired social behavior, VTA SHANK3 downregulation also elevated self-grooming and altered sucrose preference, albeit only at low sucrose concentrations. These findings may reflect a more general deficit in processing natural rewards, which could contribute to the failure of shShank3 mice to maintain social preference. Alternatively, since reduced sucrose preference was seen in the context of increased water consumption, this observation, together with elevated self-grooming, may point to increased repetitive behaviors in VTA SHANK3 mice. Although more robust and precise assays for repetitive behaviors are needed to firmly establish this, repetitive behaviors have been observed in several other Shank3 mouse models 16, 18 and are thought to recapitulate the repetitive behavior observed in patients with ASDs. Dopamine has been linked to repetitive behaviors in several studies via its actions on corticostriatal circuits 43 . Since our manipulation is selective for the VTA, the repetitive behaviors observed may arise from altered function of ventral striatum, producing npg a r t I C l e S changes in the motivational aspects of behavioral control. A future challenge is to understand how the encoding of distinct repetitive and social behaviors is distributed across mesocorticolimbic circuits.
Finally, our study confirms mGluR1 activation in VTA DA neurons during the early postnatal period as an essential determinant of postnatal development, which may be deficient in certain forms of ASD. We provide a proof of principle that under conditions of low SHANK3 levels, treatment with a positive allosteric modulator of mGluR1 can overcome deficits in postnatal development. However, it remains unknown whether the VTA dysfunction and response to mGluR1 modulation observed in VTA SHANK3 mice is also present in global loss-of-function Shank3 mutants that more closely reflect the etiology associated with SHANK3 mutations found in ASD. Nevertheless, the pharmacological rescue of both neuron function and behavior in VTA SHANK3 mice persists into adulthood and suggests that mGluR1 may be a valid target for the early treatment of some form of ASDs.
METHODS
Methods and any associated references are available in the online version of the paper. 
ONLINE METHODS
Animals.
The study was conducted with wild-type C57Bl/6j (WT), DATiresCre (Slc6a3 tm1.1(cre)Bkmn ) and GAD-Cre (65-kDa isoform of the Gad2 locus 44 ) male and female mice housed in groups (weaning at P21-P23) under a normal light-dark cycle (lights on at 7.00 a.m.). All the physiology and behavior experiments were performed during the light cycle. All the procedures performed at the UNIL and UNIGE compiled with the Swiss National Institutional Guidelines on Animal Experimentation and were approved by the Swiss Cantonal Veterinary Office Committee for Animal Experimentation. All procedures performed at Bordeaux were conducted in accordance with the European directive 2010-63-EU and with approval from Bordeaux University Animal Care and Use Committee (no. 50120205-A). All experiments were performed blindly to the experimenter, and within each litter the mice were randomly assigned to both virus and pharmacological treatments.
The number of animals used for each experiment is reported per group in each figure legend. No statistical methods were used to predetermine sample sizes, but our sample sizes are similar to those generally employed in the field.
electrophysiology. Horizontal midbrain slices 200-250 µm thick containing VTA were prepared following the experimental injection protocols described in the text. Slices were kept in artificial cerebrospinal fluid containing 119 mM NaCl, 2.5 mM KCl, 1.3 mM MgCl 2 , 2.5 mM CaCl 2 , 1.0 mM NaH 2 PO 4 , 26.2 mM NaHCO 3 and 11 mM glucose, bubbled with 95% O 2 and 5% CO 2 . Whole-cell voltage-clamp recording techniques were used (30-32 °C, 2-3 ml min −1 , submerged slices) to measure the holding currents and synaptic responses of VTA neurons, with recordings made medially to the medial terminal nucleus of the accessory optic tract (MT). Putative DA and GABA neurons were classified according to the following criteria: large/small soma, cell capacitance (for putative DA neuron >28 pF, for putative GABA neuron <27 pF), hyperpolarization step (−60 mV, 500 ms duration immediately after whole-cell patch clamp configuration) induced I h current presence/absence and input resistance (monitored for 2 min after the whole-cell patch clamp configuration at +40 mV). Recordings were performed from uninfected, shShank3-infected and scrShank3-infected cells (identified by the expression of the green reporter protein) and sorted as putative DA or putative GABA neurons as described above. The internal solution contained 130 mM CsCl, 4 mM NaCl, 2 mM MgCl 2 , 1.1 mM EGTA, 5 mM HEPES, 2 mM Na 2 ATP, 5 mM sodium creatine phosphate, 0.6 mM Na 3 GTP and 0.1 mM spermine. Currents were amplified, filtered at 5 kHz and digitized at 20 kHz. The liquid junction potential was small (−3 mV) and traces were therefore not corrected.
Access resistance was monitored by a hyperpolarizing step of −14 mV at each sweep, every 10 s. The cells were recorded at the access resistance from 10-30 MΩ for putative DA neurons and 15-40 MΩ for putative GABA neurons. Data were excluded when the resistance changed >20%. Synaptic currents were evoked by stimuli (0.05-0.10 ms) at 0.1 Hz through a stimulating electrode placed rostral to the VTA. The experiments were carried out in the presence of the GABA A receptor antagonist picrotoxin (100 µM); the AMPAR EPSCs were pharmacologically isolated by application of the NMDAR antagonist d-APV (50µM) and NMDAR EPSCs were recorded at +40 mV in presence of the AMPAR blocker NBQX (10 µM). Representative example traces are shown as the average of 15-20 consecutive EPSCs typically obtained at each potential. The rectification index of AMPARs is the ratio of the chord conductance calculated at negative potential (−60 mV) divided by the chord conductance at positive potential (+40 mV). The analysis of the decay time of NMDAR-mediated EPSC was conducted as described previously 45 and the ifenprodil sensitivity was calculated as the percentage of NMDAR EPSC amplitude reduction (at +40 mV) after 20-25 min of continuous ifenprodil (3 µM, GluN2B-containing NMDAR antagonist) bath application compared to baseline. The time interval between the two stimulations for the PPR measurement was 50 ms (interstimulation interval, ISI) and the ratio was obtained by dividing the EPSC 2 by EPSC 1 amplitude at −60 mV. The in vitro validation of the optogenetic protocol (used in vivo) was performed in current-clamp configuration, after the assessment of the I h current and the desensitization current (500 ms pulse duration) in voltage-clamp mode. The internal solution contained 140 mM potassium gluconate, 2 mM MgCl 2 , 5 mM KCl, 0.2 mM EGTA, 10 mM HEPES, 4 mM Na 2 ATP, 0.3 mM Na 3 GTP and 10 mM creatine phosphate. Blue light was delivered through the 40× objective focused on the cell soma with a power intensity of 8 mW. Synaptic responses were collected with a Multiclamp 700B amplifier (Axon Instruments, Foster City, CA), filtered at 2.2 kHz, digitized at 5 Hz, and analyzed online using Igor Pro software (Wavemetrics, Lake Oswego, OR).
Stereotaxic injections.
Injections of purified AAV-shShank3, AAV-scrShank3 and AAV-CAG-DIO-tdTomato were performed in mice at different time points. Anesthesia was induced and maintained with a mixture of oxygen and isoflurane (Baxter AG, Vienna, Austria). The animals were then placed on the stereotaxic frame (Angle One; Leica, Germany) and a single or bilateral craniotomy was made over the VTA at following stereotaxic coordinates: for neonatal injections (P2-P5), ML 0.15 mm, AP 0.1 mm, DV −3.8 mm from lambda; for juvenile injections (P14/P21/P24), ML ± 0.5 mm, AP −3.2 mm, DV −4.0 mm from bregma. The virus was injected with graduated pipettes (Drummond Scientific Company, Broomall, PA) at the rate of 100 nl/min for a total volume of 50 and 200 nL for neonatal (as reported in the text) and 400 nL for juvenile animals. For all the experiments the virus was incubated for at least 9 d, at which point expression was clearly identifiable by the reporter protein expression, before proceeding with further manipulations.
In vivo single-unit neuron recordings. A glass micropipette (tip diameter: 2-3 µm; 4-6 MΩ for VTA dopamine neurons and tip diameter: 1-2 µm, 10-15 MΩ for VTA putative GABA neurons) filled with 2% pontamine sky blue solution in 0.5 M sodium acetate was lowered into the VTA. VTA dopamine neurons were identified according to well-established electrophysiological features [46] [47] [48] , which included the following: (1) an action potential with 1.1 ms (measured from the start of action potential to the negative trough); (2) slow spontaneous firing rate (10 Hz); (3) single and burst spontaneous firing patterns composed of 2-10 spikes in vivo. The onset of a burst was defined with an interspike interval lower than 80 ms and the end of the burst with an interspike interval higher than 160 ms (ref. 31) . Putative VTA GABA neurons were identified according to well-established electrophysiological criteria: (1) an action potential width <1.1 ms; (2) a location within the VTA, with the VTA boundary defined as 200 µm dorsal to the first VTA DA neuron recorded 31, 32, 49, 50 . The extracellular potential was recorded with an Axoclamp-2B amplifier and filter (300 Hz/0.5 kHz) 51 . Single neuron spikes were collected online (CED 1401, SPIKE 2; Cambridge Electronic Design). Four parameters for VTA dopamine neuron firing and bursting activity were analyzed: the cumulative probability distribution of the firing rate, the bursting rate and the index of bursting (burst event frequency × mean spikes per burst).
immunohistochemistry and cell counting. Mice were killed and transcardially perfused with PBS 1× followed by 4% paraformaldehyde prepared in PBS 1×. The brain was removed and left for overnight postfixation at 4 °C. Horizontal VTA slices were cut at 50 µm and washed three times in PBS 1× before incubation in the blocking solution containing 0.3% Triton X-100 and 1% goat serum. The slices were incubated with rabbit anti-TH (Abcam ab112, 1:500) at 4 °C overnight and then washed three times in PBS 1× and incubated for 2 h at room temperature with secondary antibodies, goat anti-rabbit IgG-Alexa 568 (Abcam, 1:500; ab175471) or goat anti-rabbit IgG-Alexa 647 (Abcam, 1:500; ab150079). Finally, the slices were washed three times in PBS 1× before being mounted onto microscope slides with Abcam DAPI mounting medium (Abcam, ab104139). Images were acquired with an LSM-710 confocal microscope.
Cell counting was performed on 50-µm-thick VTA slices from at least 4 WT mice and 3 GAD-Cre mice injected with shShank3 (at P5) and AAV-CAG-DIOtdTomato (at P14). All slices were collected and immunohistochemistry against TH was performed for every other slice (secondary antibody IgG-Alexa 568 for WT and IgG-Alexa 647 for GAD-Cre:tdTomato mice). Two confocal images of VTA were acquired bilaterally for each slice, along the whole VTA dorsoventral axis in the dopaminergic area. For WT, the number of TH + , ZsGreen + and TH + ZsGreen + cells were counted in at least 6 fields of view per mouse, and a percentage average calculated for each mouse. The total percentage average (Supplementary Fig. 1b) was calculated as an average of the values from each mouse. To count the total number of TH-positive cells, the VTA was unilaterally infected and sliced at the juvenile stage and cell counting performed as described above (Supplementary Fig. 1c) . Cell-counting from GAD-Cre:tdTomato was performed by two independent experimenters. Specifically, the number of TH + , TH + ZsGreen + , tdTom + and tdTom + ZsGreen + was counted in each field of view of the VTA along the whole dorso-ventral axis (at least 6 fields). The percentage of cells obtained by each experimenter was averaged for each mouse. The total percentage of infected cells (Fig. 1b) was obtained by averaging the percentage obtained for each mouse.
western blot analysis. AAV-shShank3-infected and AAV-scrShank3-infected mice (P21-P35) were anesthetized and decapitated. Midbrain slices 350 µm thick were obtained with a vibratome (Leica VT1200S). The VTA and the adjacent SN were dissected in animals that showed virus expression (one mouse was excluded from shShank3 group because it was not infected), isolated and homogenized in a lysis buffer containing 20 mmol/L HEPES, pH 7.4, 10 mmol/L NaCl, 3 mmol/L MgCl2, 2.5 mmol/L EGTA, 0.1 mmol/L dithiothreitol, 50 mmol/L NaF, 1 mmol/L Na 3 VO 4 , 1% Triton X-100 and a protease inhibitor cocktail (Roche). Lysates were boiled for 5 min and separated on a denaturing 5-9% acrylamide gel. The following primary antibodies were used: Shank3 (H-160) (sc-30193, Santa Cruz Biotechnology, 1:200) and tubulin (sc-8035,Santa Cruz Biotechnology, 1:1,000). The following secondary antibodies were used: goat-anti-rabbit, goat-anti-mouse coupled with IRdye 800 or IRdye 680 (936-32210, 926-32220, LiCor, Lincoln, 1:10,000). Protein bands were revealed by the Odyssey infrared image system (LiCor).
Social interaction test.
A three-chambered social preference test was used, comprising a rectangular Plexiglas arena (60 × 40 × 22 cm) (Ugo Basile, Varese, Italy) divided into three chambers (each 20 × 40 × 22 (h) cm). The walls of the center chamber had doors that could be lifted to allow free access to all chambers. The social preference test was performed similarly as published by Moy et al. 52 and the variables were scored and calculated as previously published 53 . Briefly, each mouse was placed in the arena for a habituation period of 10 min, when it was allowed to freely explore the empty arena. At the end of the habituation, the test was performed: two enclosures with metal vertical bars were placed diagonally, one in the bottom left corner of the left compartment and one in the top right corner of the right compartment. One enclosure was empty (serving as an inanimate object) whereas the other contained a social stimulus (unfamiliar juvenile mouse 25 ± 1 d old). The enclosures allowed visual, auditory, olfactory and tactile contact between the experimental mice and the mice acting as social stimuli. The juvenile mice in the enclosures were habituated to the apparatus and the enclosures for a brief period of time on the 3 d preceding the experiment. The experimental mouse was allowed to freely explore the apparatus and the enclosures for 10 min. The position of the empty vs. juvenile-containing enclosures alternated and was counterbalanced for each trial to avoid any bias effects.
Every session was video-tracked and recorded using Ethovision XT (Noldus, Wageningen, the Netherlands), which provided an automated recording of the entries around the enclosures, the distance moved and the velocity. Behavior was also manually scored by an experimenter blind to the treatment of animals. The mice were considered to be exploring the empty and the social stimulus when their nose was directed toward the enclosures' contents at a distance less than approximately 2 cm. The time spent sniffing each enclosure was assessed and then used to determine the preference score for the social target as compared to the empty enclosure (social/(social + empty)). To investigate the dynamics of social preference between groups across time, we divided the test phase into two 5-min bins and calculated the social preference ratios for these two time points (T 1 and T 2 ). Moreover, the normalized social preference at T 2 (SP 2 ) was calculated by dividing the social preference score at T 2 by the social preference score for the total testing time. The change in the interaction with the mouse was calculated between T 1 and T 2 (time of interaction with social target at T 2 − time of interaction with social target at T 1 ), and the change in interaction for the empty enclosure was calculated similarly. The arena was cleaned with 1% acetic acid solution and dried between trials.
Social memory task. For the cohort of mice injected in the VTA with 50 nL of AAV-shShank3 or AAV-scrShank3, a social memory task was performed. Following the social preference test performed as described above, a novel mouse was introduced into the formerly empty enclosure. Mice were exposed to the enclosures containing the novel and the familiar mouse for 10 min. Time spent sniffing each enclosure was assessed and the preference score for the novel mouse compared to the familiar (novel/(novel + familiar)) was calculated. The social memory test was also divided into two 5-min bins and social memory calculated during T 1 and T 2 . As reported for the social preference test, the normalized social memory at T 2 (SM 2 ) was calculated by dividing the social memory score at T 2 by the social memory score for the total testing time. The change in the interaction with the novel mouse was calculated between T 1 and T 2 (time of interaction with novel mouse during T 2 − time of interaction with novel mouse during T 1 ), and the change in interaction was calculated similarly for the familiar mouse.
optogenetic stimulation during the social preference test. AAV-shShank3-infected and AAV-scrShank3-infected DAT-Cre mice underwent a second stereotaxic surgery at 4-5 weeks of age to inject 250-500 nL of AAV5-ef1a-ChR2(H134R)-eYFP into the VTA (−3.2 AP, +0.9 ML and −4.28 DV at a 10° angle), together with a single fiber optic cannula at the same coordinates, but positioned approximately 0.1 mm above the ChR2 infection site 35 . Following at least 2 weeks of recovery, mice were first habituated to a patch cable during 3 × 30 min sessions preceding the social preference test. The social preference test was performed as described above, except that mice assigned to the 'ON' condition received phasic blue light stimulation of VTA DA neurons only when they entered in close proximity to the social stimulus during T 2 . Laser power was controlled between each test to ensure an estimated 7-10 mW of power at the implanted fiber tip.
open field test.
The open field was a 75-cm diameter Plexiglas circular arena, divided into three virtual zones (wall, intermediate and center). Animals were allowed to freely explore the open field for 10 min and their behavior was automatically (Ethovision, Noldus, Wageningen, the Netherlands) and manually scored (for assessing self-grooming behavior). Parameters analyzed with the automated tracking system were distance, velocity and time in the different zones. The arena was cleaned with 1% acetic acid and dried between each test.
Sucrose preference test. Mice were housed individually for the duration of this task (48 h) and had access to standard lab chow and tap water throughout the experiment. At 18 h they were exposed to two drinking bottles, one with water and the other one containing sucrose solution. During the first testing day, sucrose was given at 1% and 24 h afterwards the bottles were weighed and subsequently the sucrose solution was given to the mice at a concentration of 8% for another 24 h, when the second measurement was taken. Mice were weighed at the beginning of the experiment and water and sucrose bottle positions were counterbalanced between animals to avoid any confounding effect of side preference. Sucrose and water consumption were normalized to 10 g of the body weight of each mouse and the amount of water and sucrose drunk was analyzed. A sucrose preference ratio was calculated as (sucrose consumed/(sucrose consumed + water consumed)). drugs and viruses. Drugs and viruses used were: AAV-shShank3/scrShank3 (AAV5, AAV1; 7.4 × 10 13 GC/mL; VectorBioLab; shShank3 shRNA sequence targeting exon 21 of the rat and mouse SHANK3 gene: 5′-GGAAGTCACC AGAGGACAAGA-3′), AAV-CAG-DIO-tdTomato (AAV9, gift from Prof. Anthony Holtmaat), rAAV5-Ef1a-DIO-hChR2(H134R)-eYFP (5 × 10 12 virus molecules/mL UNC). Ro 677476 (4346, Tocris), D-APV (0106, Tocris), picrotoxin (1128, Tocris), NBQX (0373, Tocris), (R,S)-3,5-DHPG (0342, Tocris) and ifenprodil hemitartrate (0545, Tocris).
Statistical analysis. The data were analyzed with independent or paired twotailed samples t-tests, one-way, two-way or repeated measures ANOVA followed up by post hoc tests (as reported in figure legends). Normality was checked with the Shapiro-Wilk criterion and, when violated, non-parametric statistics were applied (Mann-Whitney and Kruskal-Wallis). Regarding t-tests, when Levene's test for the equality of variances was significant, suggesting that equal variances could be not assumed, the adjusted values and degrees of freedom are reported. All bars and error bars represent the mean ± s.e.m., and significance was set at P < 0.05. The data were analyzed using the statistical package SPSS (SPSS, Chicago, IL, USA) versions 17.0 and 22.0 and Graphpad Prism 5 and 6, and the graphs were created using GraphPad Prism 5 and 6 (San Diego, CA, USA). For the behavioral experiments 2 animals out of 60 were excluded from the analysis, as 1 was not infected in the VTA (shShank3:Vehicle) and another did not show any social preference during T 1 (scrShank3:Ro).
A Supplementary methods checklist is available.
npg
